These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27795392)

  • 1. HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation.
    Remoli AL; Marsili G; Perrotti E; Acchioni C; Sgarbanti M; Borsetti A; Hiscott J; Battistini A
    mBio; 2016 Oct; 7(5):. PubMed ID: 27795392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.
    Sgarbanti M; Borsetti A; Moscufo N; Bellocchi MC; Ridolfi B; Nappi F; Marsili G; Marziali G; Coccia EM; Ensoli B; Battistini A
    J Exp Med; 2002 May; 195(10):1359-70. PubMed ID: 12021315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat potently stabilises Mdm2 and enhances viral replication.
    Raja R; Ronsard L; Lata S; Trivedi S; Banerjea AC
    Biochem J; 2017 Jul; 474(14):2449-2464. PubMed ID: 28468838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-binding regulates site-specific ubiquitination of IRF-1.
    Landré V; Pion E; Narayan V; Xirodimas DP; Ball KL
    Biochem J; 2013 Feb; 449(3):707-17. PubMed ID: 23134341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune regulator ABIN1 suppresses HIV-1 transcription by negatively regulating the ubiquitination of Tat.
    Chen S; Yang X; Cheng W; Ma Y; Shang Y; Cao L; Chen S; Chen Y; Wang M; Guo D
    Retrovirology; 2017 Feb; 14(1):12. PubMed ID: 28193275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PJA2 ubiquitinates the HIV-1 Tat protein with atypical chain linkages to activate viral transcription.
    Faust TB; Li Y; Jang GM; Johnson JR; Yang S; Weiss A; Krogan NJ; Frankel AD
    Sci Rep; 2017 Mar; 7():45394. PubMed ID: 28345603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.
    Brès V; Kiernan RE; Linares LK; Chable-Bessia C; Plechakova O; Tréand C; Emiliani S; Peloponese JM; Jeang KT; Coux O; Scheffner M; Benkirane M
    Nat Cell Biol; 2003 Aug; 5(8):754-61. PubMed ID: 12883554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1.
    Remoli AL; Marsili G; Perrotti E; Gallerani E; Ilari R; Nappi F; Cafaro A; Ensoli B; Gavioli R; Battistini A
    Biochem J; 2006 Jun; 396(2):371-80. PubMed ID: 16512786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination.
    Castaldello A; Sgarbanti M; Marsili G; Brocca-Cofano E; Remoli AL; Caputo A; Battistini A
    J Cell Physiol; 2010 Sep; 224(3):702-9. PubMed ID: 20432465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.
    Faust TB; Li Y; Bacon CW; Jang GM; Weiss A; Jayaraman B; Newton BW; Krogan NJ; D'Orso I; Frankel AD
    Elife; 2018 May; 7():. PubMed ID: 29845934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication.
    Ali A; Farooqui SR; Banerjea AC
    J Biol Chem; 2019 May; 294(18):7283-7295. PubMed ID: 30885946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat predominantly associates with host promoter elements in HIV-1-infected T-cells - regulatory basis of transcriptional repression of c-Rel.
    Dhamija N; Choudhary D; Ladha JS; Pillai B; Mitra D
    FEBS J; 2015 Feb; 282(3):595-610. PubMed ID: 25472883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.
    Green MV; Thayer SA
    J Neurosci; 2016 Dec; 36(50):12640-12649. PubMed ID: 27810933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the IRF-1 enhancer domain in signalling polyubiquitination and degradation.
    Pion E; Narayan V; Eckert M; Ball KL
    Cell Signal; 2009 Oct; 21(10):1479-87. PubMed ID: 19450680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tat basic domain: A "Swiss army knife" of HIV-1 Tat?
    Kurnaeva MA; Sheval EV; Musinova YR; Vassetzky YS
    Rev Med Virol; 2019 Mar; 29(2):e2031. PubMed ID: 30609200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET.
    Chiozzini C; Toschi E
    Curr Drug Targets; 2016; 17(1):33-45. PubMed ID: 26302810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+ T lymphocytes.
    Sagnier S; Daussy CF; Borel S; Robert-Hebmann V; Faure M; Blanchet FP; Beaumelle B; Biard-Piechaczyk M; Espert L
    J Virol; 2015 Jan; 89(1):615-25. PubMed ID: 25339774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tits and bits of HIV Tat protein.
    Johri MK; Mishra R; Chhatbar C; Unni SK; Singh SK
    Expert Opin Biol Ther; 2011 Mar; 11(3):269-83. PubMed ID: 21204735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.